1 suspended. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
Follow Akita University Hospital: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer Peptide vaccine for URLC10, Gemcitabine - Bile Duct Cancer | Phase 1 | Suspended | Akita University Hospital | 9 | 2008-02-01 | 2015-06-23 |
Gemcitabine (1) · LY6K protein, human (1) · Protein Subunit Vaccines (1)
Japan (1)